U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07922330) titled 'A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes' on Oct. 13.
Brief Summary: This study will evaluate the efficacy and safety of AZD6234 compared with placebo in adults who are overweight or obese, with or without type 2 diabetes mellitus.
Study Start Date: Jan. 04, 2027
Study Type: INTERVENTIONAL
Condition:
Obesity
Overweight
Type 2 Diabetes Mellitus
Intervention:
DRUG: AZD6234
administered once weekly.
DRUG: Placebo
Matching placebo administered once weekly.
Recruitment Status: NOT_YET...